TBT – SGLT-2 Inhibitors in Heart Failure

Welcome back Rounds Table Listeners!

In this throwback episode, Mike and John explore two papers exploring the use of SGLT-2 Inhibitors in heart failure. Check it out below!

  1. Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction (0:00 – 7:20).

  2. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials (7:20 – 15:45).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more